| NCT ID | NCT06838793 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Musculoskeletal Diseases or Conditions |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-03-04 |
| Primary Completion | 2026-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-03-04 with a primary completion date of 2026-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the quality of recovery after video-assisted thoracoscopic surgery (VATS) by comparing the efficacy of a single-level intertransverse process block (ITPB) against a three-level ITPB, with particular attention to the quality of recovery measured by the QoR15 score at 24 hours post-surgery.
Eligibility Criteria
Inclusion Criteria: * ASA I-III patients * 18 to 80 years of age * Patients with primary carcinoma lung scheduled for resection under VATS procedure Exclusion Criteria: * Patient refusal * Local skin infection at the area of injection * Coagulopathy * History of allergy to local anaesthetics
Contact & Investigator
Manoj K Karmakar, MD, FRCA
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT06838793 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Musculoskeletal Diseases or Conditions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06838793 currently recruiting?
Yes, NCT06838793 is actively recruiting participants. Contact the research team at aylawong@cuhk.edu.hk for enrollment information.
Where is the NCT06838793 trial being conducted?
This trial is being conducted at New Territories, Hong Kong.
Who is sponsoring the NCT06838793 clinical trial?
NCT06838793 is sponsored by Chinese University of Hong Kong. The principal investigator is Manoj K Karmakar, MD, FRCA at Chinese University of Hong Kong. The trial plans to enroll 80 participants.